Skip to main content
INKON Life Technology Co., Ltd. logo

INKON Life Technology Co., Ltd. — Investor Relations & Filings

Ticker · 300143 ISIN · CNE100000XF6 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,851 across all filing types
Latest filing 2024-12-06 Capital/Financing Update
Country CN China
Listing Shenzhen Stock Exchange 300143

About INKON Life Technology Co., Ltd.

https://www.inkonlife.com

INKON Life Technology Co., Ltd. specializes in the development and manufacture of advanced medical equipment and digital healthcare solutions. The company focuses on two primary sectors: radiotherapy equipment and digital medical services. Its core product portfolio includes high-precision radiotherapy systems, such as the Gamma Knife, and medical infusion systems. INKON Life leverages Internet of Things (IoT) technology to provide integrated digital hospital solutions, aiming to improve clinical efficiency and patient outcomes. The company serves oncology centers and medical institutions by providing comprehensive cancer treatment solutions and smart healthcare management platforms. By combining medical engineering with digital innovation, INKON Life focuses on the modernization of radiotherapy and the digital transformation of healthcare delivery.

Recent filings

Filing Released Lang Actions
关于注销部分回购股份减少注册资本暨通知债权人的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement by 盈康生命科技股份有限公司 regarding the cancellation of part of its repurchased shares and the consequent reduction in registered capital. It includes detailed information for creditors about their rights and the process for debt claims. The document references prior board and shareholder meetings where the relevant proposals were approved and mentions compliance with company law and stock exchange regulations. It is a formal notification related to corporate actions affecting capital structure but does not contain financial statements or detailed financial performance data. The document is relatively short (1539 characters) and serves as a formal announcement to stakeholders rather than a full financial report or detailed management discussion. Therefore, it fits best into the category of Capital/Financing Update (CAP), which covers updates on company fundraising, financing activities, or capital structure changes such as share cancellations and capital reduction.
2024-12-06 Chinese
2024年第三次临时股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a detailed announcement of the resolutions passed at the 2024 third extraordinary general meeting of shareholders of 盈康生命科技股份有限公司. It includes information about the meeting's convening, attendance, voting results on specific proposals, and legal opinions confirming the validity of the meeting and its resolutions. There is no financial data or report content, but rather the official voting results and procedural details of the shareholder meeting. This matches the definition of a Declaration of Voting Results & Voting Rights Announcements (DVA). The document length and content confirm it is not a brief report publication announcement or a regulatory filing. Therefore, the classification is DVA with high confidence.
2024-12-06 Chinese
关于召开2024年第三次临时股东大会的提示性公告
Regulatory Filings Classification · 95% confidence The document is a detailed announcement about the convening of the 2024 third extraordinary general meeting of shareholders, including meeting date, voting procedures, proposals to be voted on, registration details, and proxy voting instructions. It does not contain financial statements or results but rather logistical and procedural information for shareholders to participate in the meeting and vote on specific proposals. The document length is 4077 characters, which is relatively short and consistent with an announcement rather than a full report. It is not a report publication announcement since it contains substantive meeting details rather than just a notice of report availability. Therefore, this document fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA) or closely related to shareholder meeting announcements. However, since it is a notice about the meeting and voting procedures before the meeting and not the actual voting results, it is best classified as a Regulatory Filing (RNS) because it is a general regulatory announcement about the shareholder meeting and voting process, not the voting results themselves or the meeting materials. Hence, the most appropriate classification is Regulatory Filings (RNS).
2024-12-03 Chinese
关于2023年限制性股票激励计划首次授予部分第一个归属期归属结果暨股份上市公告
Board/Management Information Classification · 95% confidence The document is a detailed announcement from 盈康生命科技股份有限公司 regarding the first vesting results and listing of shares under the 2023 restricted stock incentive plan. It includes extensive information about the stock incentive plan, vesting conditions, performance targets, approval procedures, share allocation, legal opinions, and related financial and legal details. The document is not a full annual or interim financial report, nor is it a simple announcement of a report publication. It is not a call transcript, earnings release, or capital update. It focuses on the management and board decisions related to the stock incentive plan and the vesting of shares, which is a form of management information about executive compensation and stock awards. Therefore, the most appropriate classification is Board/Management Information (MANG), as it announces management-related stock incentive plan vesting and related board approvals.
2024-11-25 Chinese
关于参加2024年度青岛辖区上市公司投资者网上集体接待日活动的公告
Regulatory Filings Classification · 95% confidence The document is a short announcement about the company's participation in an investor online collective reception day event organized by regulatory and industry bodies. It mentions interaction with investors on topics like governance, strategy, and financing plans but does not contain any financial statements, detailed reports, or voting results. The length is only 491 characters, indicating it is a brief announcement rather than a full report or transcript. It is not a call transcript since it is an announcement of a future event, not a transcript of a call. It does not fit into categories like Annual Report, Earnings Release, or Management Reports. The best fit is Regulatory Filings (RNS) as a general announcement that does not fit other categories.
2024-11-24 Chinese
关于召开2024年第三次临时股东大会的通知
AGM Information Classification · 95% confidence The document is a notice about convening the 2024 third extraordinary general meeting of shareholders for 盈康生命科技股份有限公司. It details the meeting date, voting procedures, proposals to be voted on, registration details, and proxy voting instructions. It does not contain financial statements or results but is an announcement related to a shareholders meeting. The document length is 4110 characters, which is relatively short and consistent with a meeting notice rather than a full report. Therefore, it fits the category of AGM Information (AGM-R) as it is the official notification and materials for the Annual or Extraordinary General Meeting.
2024-11-21 Chinese

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.